Updated 2026-03-13 · NCT07470749See eligibility →
Country
Clinical trials in Bangladesh
Active obesity and GLP-1 studies with at least one location in Bangladesh.
5active studies
2recruiting now
1countries represented
3largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 2, Phase 3
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
Updated 2025-04-02 · NCT06896981See eligibility →
Updated 2025-08-03 · NCT07099742See eligibility →
Updated 2024-09-27 · NCT06616961See eligibility →
Active, not recruitingPhase 3
Efficacy and Safety of Tirzepatide for Weight Management
Updated 2025-04-09 · NCT06918405See eligibility →
Related countries
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.